MedTrace Logo

Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)

NCT01404923 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 436

Last updated 2014-11-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effectiveness of 2 IBS treatment strategies:

* Strategy A = MeteoSpasmyl®, on-demand therapy
* Strategy B = standard of care chosen by the physician

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

anti spasmodic agents

best standard of care prescriptions

DRUG

alverine citrate, simeticone

on-demand therapy

Sponsors & Collaborators

  • Laboratoires Mayoly Spindler

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-10-31
Completion
2011-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01404923 on ClinicalTrials.gov